US Broker Ratings

Alnylam Pharmaceuticals (ALNY) Investor Outlook: Analyzing the 46% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, is capturing investor attention with a significant potential upside of 46.12%. With a market capitalization..

Tenet Healthcare (THC) Stock Analysis: Navigating a 10.32% Potential Upside in the Healthcare Sector

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable player within the U.S. healthcare industry, boasting a market capitalization of $20.42 billion. As an entity operating..

ResMed Inc. (RMD) Stock Analysis: Evaluating a 17.79% Potential Upside for Investors

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, specializes in developing innovative medical devices and cloud-based software applications to manage respiratory disorders. With..

IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Exploring a 19.21% Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within diagnostics and research, is currently capturing the attention of investors with its..

argenx SE (ARGX) Stock Analysis: Biotechnology Giant with 25.90% Upside Potential

Investors with an eye on the biotechnology sector might find argenx SE (NASDAQ: ARGX) a compelling opportunity, particularly given its significant market cap of $50.87 billion...

Sanofi (SNY) Stock Analysis: A 25% Potential Upside with Strong Dividend Yield

Sanofi (SNY), a global healthcare leader headquartered in Paris, France, is making waves in the pharmaceutical industry with its robust portfolio of therapeutic solutions and vaccines...

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Uncovering a 10% Upside Potential for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the global healthcare sector, continues to capture the attention of investors seeking growth in the drug..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 6.24% Dividend Yield Amidst Market Complexity

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to captivate investors with its robust portfolio of biopharmaceutical products and a compelling dividend yield..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a 9.1% Revenue Growth in Healthcare

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, is navigating a complex landscape with a market cap standing tall at $586.69 billion. As..

STERIS plc (STE) Stock Analysis: Attractive Growth Potential with 13.25% Upside

STERIS plc (NYSE: STE) is a prominent player in the medical devices industry, renowned for its infection prevention products and services. Operating globally, STERIS is structured..

DexCom, Inc. (DXCM) Stock Analysis: A Compelling 22% Upside Amidst Growing Healthcare Demand

Investors in the healthcare sector might find DexCom, Inc. (DXCM) an intriguing prospect, especially considering its pivotal role in the medical devices industry. With a market..

Novartis AG (NVS) Stock Analysis: Navigating Growth with a 2.93% Dividend Yield in the Healthcare Sector

For individual investors seeking opportunities in the healthcare sector, Novartis AG (NYSE: NVS) presents an intriguing case. As a Swiss pharmaceutical giant, Novartis commands a market..

Danaher Corporation (DHR) Stock Analysis: Exploring a 24.62% Potential Upside and Strong Buy Ratings

Danaher Corporation (NYSE: DHR) stands as a formidable entity within the Healthcare sector, specifically in the Diagnostics & Research industry. With a market capitalization of $150.27..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating Growth Potential and Market Position

Investors seeking a robust presence in the healthcare sector should consider HCA Healthcare, Inc. (NYSE: HCA), a titan in the medical care facilities industry with a..

Medtronic plc (MDT) Stock Analysis: Riding the Upside Wave with 12.57% Potential Growth

Medtronic plc (MDT), headquartered in Galway, Ireland, stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Biotech Innovator with Over 105% Potential Upside

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of cancer therapies and..

MBX Biosciences, Inc. (MBX) Stock Analysis: A Biotech with a 60.79% Potential Upside

MBX Biosciences, Inc. (MBX) is making waves in the biotechnology sector with its focus on precision peptide therapies aimed at treating endocrine and metabolic disorders. With..

Septerna, Inc. (SEPN) Stock Analysis: Biotechnology Pioneer with 31.43% Upside Potential

Septerna, Inc. (SEPN), a burgeoning name in the biotechnology sector, has captured investor attention with its remarkable revenue growth and potential upside. As a clinical-stage biotech..

Abivax SA (ABVX) Stock Analysis: A 22.77% Potential Upside and Strong Buy Consensus

Abivax SA (ABVX), a French biotechnology powerhouse, is drawing significant investor attention with its promising potential upside of 22.77% as indicated by analyst targets. Operating at..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Biotechnology Player with a 60% Upside Potential

As a relatively new entrant in the healthcare sector, Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology industry. Incorporated in 2023 and headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds